RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis

被引:34
作者
Suarez-Calvet, Xavier [1 ,2 ,3 ]
Gallardo, Eduard [1 ,2 ,3 ]
Pinal-Fernandez, Iago [4 ]
De Luna, Noemi [1 ,2 ,3 ]
Lleixa, Cinta [1 ,2 ,3 ]
Diaz-Manera, Jordi [1 ,2 ,3 ]
Rojas-Garcia, Ricardo [1 ,2 ,3 ]
Castellvi, Ivan [5 ]
Angeles Martinez, M. [6 ]
Grau, Josep M. [3 ,7 ]
Selva-O'Callaghan, Albert [4 ]
Illa, Isabel [1 ,2 ,3 ]
机构
[1] Univ Autonoma Barcelona, Neuromuscular Dis Unit, Neurol Dept, Hosp Santa Creu & St Pau, St Antoni Maria Claret 167, Barcelona 08025, Spain
[2] Univ Autonoma Barcelona, Inst Recerca St Pau, St Antoni Maria Claret 167, Barcelona 08025, Spain
[3] Ctr Biomed Network Res Rare Dis CIBERER, Madrid, Spain
[4] Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Internal Med, Autoimmune Syst Dis Unit, Barcelona, Spain
[5] Hosp Santa Creu & Sant Pau, Rheumatol Unit, Barcelona, Spain
[6] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Immunol Dept, Barcelona, Spain
[7] Hosp Clin Barcelona, Internal Med Serv, Muscle Res Unit, Barcelona, Spain
关键词
Inflammatory myopathies; Dermatomyositis; Biomarker; Muscle biopsy; Perifascicular atrophy; INTERFERON; ANTIBODIES; MECHANISMS;
D O I
10.1186/s13075-017-1383-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Dermatomyositis (DM) is inflammatory myopathy or myositis characterized by muscle weakness and skin manifestations. In the differential diagnosis of DM the evaluation of the muscle biopsy is of importance among other parameters. Perifascicular atrophy in the muscle biopsy is considered a hallmark of DM. However, perifascicular atrophy is not observed in all patients with DM and, conversely, perifascicular atrophy can be observed in other myositis such as antisynthetase syndrome (ASS), complicating DM diagnosis. Retinoic acid inducible-gene I (RIG-I), a receptor of innate immunity that promotes type I interferon, was observed in perifascicular areas in DM. We compared the value of RIG-I expression with perifascicular atrophy as a biomarker of DM. Methods: We studied by immunohistochemical analysis the expression of RIG-I and the presence of perifascicular atrophy in 115 coded muscle biopsies: 44 patients with DM, 18 with myositis with overlap, 8 with ASS, 27 with non-DM inflammatory myopathy (16 with polymyositis, 6 with inclusion body myositis, 5 with immune-mediated necrotizing myopathy), 8 with muscular dystrophy (4 with dysferlinopathy, 4 with fascioscapulohumeral muscle dystrophy) and 10 healthy controls. Results: We found RIG-I-positive fibers in 50% of DM samples vs 11% in non-DM samples (p < 0.001). Interestingly, RIG-I staining identified 32% of DM patients without perifascicular atrophy (p = 0.007). RIG-I sensitivity was higher than perifascicular atrophy (p < 0.001). No differences in specificity between perifascicular atrophy and RIG-I staining were found (92% vs 88%). RIG-I staining was more reproducible than perifascicular atrophy (K coefficient 0.52 vs 0.37). Conclusions: The perifascicular pattern of RIG-I expression supports the diagnosis of DM. Of importance for clinical and therapeutic studies, the inclusion of RIG-I in the routine pathological staining of samples in inflammatory myopathy will allow us to gather more homogeneous subgroups of patients in terms of immunopathogenesis.
引用
收藏
页数:7
相关论文
共 16 条
  • [1] Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy
    Aouizerate, Jessie
    De Antonio, Marie
    Bassez, Guillaume
    Gherardi, Romain K.
    Berenbaum, Francis
    Guillevin, Loic
    Berezne, Alice
    Valeyre, Dominique
    Maisonobe, Thierry
    Dubourg, Odile
    Cosnes, Anne
    Benveniste, Olivier
    Authier, Francois Jerome
    [J]. ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2014, 2
  • [2] Type I interferon and Toll-like receptor expression characterizes inflammatory myopathies
    Cappelletti, C.
    Baggi, F.
    Zolezzi, F.
    Biancolini, D.
    Beretta, O.
    Severa, M.
    Coccia, E. M.
    Confalonieri, P.
    Morandi, L.
    Mora, M.
    Mantegazza, R.
    Bernasconi, P.
    [J]. NEUROLOGY, 2011, 76 (24) : 2079 - 2088
  • [3] Inflammatory Muscle Diseases
    Dalakas, Marinos C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (18) : 1734 - 1747
  • [4] Interferon-α/β-mediated innate immune mechanisms in dermatomyositis
    Greenberg, SA
    Pinkus, JL
    Pinkus, GS
    Burleson, T
    Sanoudou, D
    Tawil, R
    Barohn, RJ
    Saperstein, DS
    Briemberg, HR
    Ericsson, M
    Park, P
    Amato, AA
    [J]. ANNALS OF NEUROLOGY, 2005, 57 (05) : 664 - 678
  • [5] Sustained autoimmune mechanisms in dermatomyositis
    Greenberg, Steven A.
    [J]. JOURNAL OF PATHOLOGY, 2014, 233 (03) : 215 - 216
  • [6] Hoogendijk Jessica E, 2004, Neuromuscul Disord, V14, P337, DOI 10.1016/j.nmd.2004.02.006
  • [7] Anti-MDA5 Antibodies in a Large Mediterranean Population of Adults with Dermatomyositis
    Labrador-Horrillo, Moises
    Angeles Martinez, Maria
    Selva-O'Callaghan, Albert
    Trallero-Araguas, Ernesto
    Balada, Eva
    Vilardell-Tarres, Miquel
    Juarez, Candido
    [J]. JOURNAL OF IMMUNOLOGY RESEARCH, 2014, 2014 : 290797
  • [8] Anti-TIF1γ antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays
    Labrador-Horrillo, Moises
    Angeles Martinez, Maria
    Selva-O'Callaghan, Albert
    Trallero-Araguas, Ernesto
    Balada, Eva
    Vilardell-Tarres, Miquel
    Juarez, Candido
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (06) : 993 - 996
  • [9] Intracellular pattern recognition receptors in the host response
    Meylan, Etienne
    Tschopp, Juerg
    Karin, Michael
    [J]. NATURE, 2006, 442 (7098) : 39 - 44
  • [10] The Prevalence of Individual Histopathologic Features Varies according to Autoantibody Status in Muscle Biopsies from Patients with Dermatomyositis
    Pinal-Fernandez, Iago
    Casciola-Rosen, Livia A.
    Christopher-Stine, Lisa
    Corse, Andrea M.
    Mammen, Andrew L.
    [J]. JOURNAL OF RHEUMATOLOGY, 2015, 42 (08) : 1448 - 1454